We are live on ! Find out more
JGIA

Jackson Grant Investment Advisers Portfolio holdings

AUM $322M
1-Year Est. Return 20.03%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+20.03%
3 Year Est. Return
+54.33%
5 Year Est. Return
+61.8%
10 Year Est. Return
+185.98%
AUM
$113M
AUM Growth
+$4M
Cap. Flow
+$454K
Cap. Flow %
0.4%
Top 10 Hldgs %
66.85%
Holding
171
New
12
Increased
133
Reduced
7
Closed
9

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$1.84M
2
ABBV icon
AbbVie
ABBV
+$1.69M
3
ABT icon
Abbott
ABT
+$440K
4
MO icon
Altria Group
MO
+$123K
5
PM icon
Philip Morris
PM
+$115K

Sector Composition

Rank Sector Weight
1 Consumer Staples 6.59%
2 Healthcare 4.29%
3 Industrials 2.33%
4 Consumer Discretionary 2.3%
5 Communication Services 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
26
Vanguard S&P 500 ETF
VOO
$1.03T
$735K 0.65%
3,824
+19
+0.5% +$3.62K
PEP icon
27
PepsiCo
PEP
$190B
$671K 0.59%
6,334
+45
+0.7% +$4.64K
MSFT icon
28
Microsoft
MSFT
$3.71T
$664K 0.59%
12,971
+1,558
+14% +$81K
GIS icon
29
General Mills
GIS
$19.7B
$610K 0.54%
8,548
+61
+0.7% +$3.88K
XLK icon
30
State Street Technology Select Sector SPDR ETF
XLK
$123B
$594K 0.52%
27,414
+2,542
+10% +$55.1K
PM icon
31
Philip Morris
PM
$295B
$582K 0.51%
5,722
-1,154
-17% -$115K
AAPL icon
32
Apple
AAPL
$4.57T
$513K 0.45%
21,472
+332
+2% +$8.25K
CL icon
33
Colgate-Palmolive
CL
$74.4B
$504K 0.44%
6,885
+37
+0.5% +$2.63K
IWC icon
34
iShares Micro-Cap ETF
IWC
$1.5B
$490K 0.43%
6,933
+207
+3% +$14.5K
PFE icon
35
Pfizer
PFE
$153B
$476K 0.42%
14,255
+284
+2% +$9.06K
BXMX
36
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$459K 0.4%
35,253
+554
+2% +$7.09K
KMB icon
37
Kimberly-Clark
KMB
$36.5B
$413K 0.36%
3,002
+19
+0.6% +$2.49K
BDJ icon
38
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$395K 0.35%
50,084
+646
+1% +$4.93K
MDT icon
39
Medtronic
MDT
$112B
$332K 0.29%
3,824
+107
+3% +$8.65K
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.13T
$320K 0.28%
2,209
LLY icon
41
Eli Lilly
LLY
$1.06T
$308K 0.27%
3,905
+26
+0.7% +$1.96K
MRK icon
42
Merck
MRK
$318B
$302K 0.27%
5,485
+46
+0.8% +$2.45K
IWM icon
43
iShares Russell 2000 ETF
IWM
$81.9B
$296K 0.26%
2,577
+88
+4% +$9.93K
CSX icon
44
CSX Corp
CSX
$93.1B
$294K 0.26%
33,840
+141
+0.4% +$1.23K
UNH icon
45
UnitedHealth
UNH
$370B
$289K 0.25%
2,050
+71
+4% +$9.47K
PPG icon
46
PPG Industries
PPG
$26.6B
$267K 0.24%
2,561
+9
+0.4% +$983
WMT icon
47
Walmart Inc
WMT
$890B
$261K 0.23%
10,725
+141
+1% +$3.26K
IVE icon
48
iShares S&P 500 Value ETF
IVE
$49.8B
$258K 0.23%
2,779
+33
+1% +$3.02K
CVX icon
49
Chevron
CVX
$366B
$229K 0.2%
2,189
+23
+1% +$2.31K
ITM icon
50
VanEck Intermediate Muni ETF
ITM
$2.13B
$220K 0.19%
4,425
+25
+0.6% +$1.22K

Similar funds

Jackson Grant Investment Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, Jackson Grant Investment Advisers held 171 positions worth $113M, up 3.7% from $109M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Jackson Grant Investment Advisers's Q2 2016 filing shows 12 new, 133 increased, 7 reduced and 9 closed positions. Its largest new stake was Berkshire Hathaway Class A: 1 share worth $217K. The largest sale was AT&T, an estimated $1.84M.

By sector, the portfolio is most concentrated in Consumer Staples at 6.6% of assets, down from 6.7% a quarter earlier, followed by Healthcare and Industrials.

  • Jackson Grant Investment Advisers's largest Q2 2016 buy was Berkshire Hathaway Class A: 1 share worth $217K.
  • Jackson Grant Investment Advisers added most to iShares Core US Aggregate Bond ETF in Q2 2016, an estimated $622K increase.
  • Jackson Grant Investment Advisers's biggest Q2 2016 reduction was Altria Group, cutting an estimated $123K.
  • Jackson Grant Investment Advisers fully exited AT&T in Q2 2016, selling an estimated $1.84M.
  • Jackson Grant Investment Advisers's ten largest holdings make up 67% of its $113M portfolio in Q2 2016.
  • Jackson Grant Investment Advisers opened 12 new positions and closed 9 in Q2 2016.
  • Jackson Grant Investment Advisers's portfolio value rose 3.7% quarter-over-quarter to $113M.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2016, filed 4 Aug 2016.